In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by targeting and removing harmful proteins from cells.
An emerging approach in medicine and research, called “Targeted Protein Degradation” (TPD), works by using …
As of Sept. 1, Professor Neil Kelleher, of the Department of Chemistry, is the new director of the Chemistry of Life Processes Institute (CLP). The CLP is a center of interdisciplinary collaboration and biomedical innovation at Northwestern that aims …
On June 22, more than 250 biotech leaders, neuroscience experts and investors gathered virtually for the third-annual Biotech by the Lake Investor Summit. The half-day program featured a series of discussions and presentations about neurological disorder breakthroughs, trends and financing …
The Chemistry of Life Processes Institute will host their third annual Biotech by the Lake Investor Summit on June 22, 2021. The theme of this year’s summit is Targeting Neurological Disorders. The online program will feature 17 academic, investment, …